ReviewFrontiers in nutrition2025
Emerging insights into the role of visceral adipose tissue in diabetic kidney disease.
Review in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multimodal Magnetic Resonance Imaging in Diabetic Kidney Disease: From Pathophysiological Insights to Clinical Applications.Diagnostics (Basel, Switzerland) · 2026Review
- New findings in diabetic kidney disease: correlation and enhanced combined diagnostic value of sclerostin and 25(OH)VD.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic kidney disease (DKD) is one of the primary microvascular complications of diabetes mellitus and the leading cause of end-stage renal disease. Obesity, which increases the risk of metabolic disorders, plays a crucial role in the onset and progression of DKD. Visceral fat area (VFA), recognized as the gold standard for diagnosing central obesity, can be accurately measured via imaging techniques. Visceral adipose tissue (VAT) regulates disease progression through a variety of potential mechanisms and promotes the occurrence and development of DKD. This review summarizes the assessment methods of VFA, the association between VAT and DKD, and the potential mechanisms by which VAT drives DKD pathogenesis, aiming to provide insights into the role of VAT assessment and its mechanisms in the prevention and treatment of DKD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.